These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1719304)

  • 1. Increased anticoagulation during cardiopulmonary bypass by aprotinin.
    Levy JH; Salmenpera MT
    J Thorac Cardiovasc Surg; 1991 Nov; 102(5):802. PubMed ID: 1719304
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased anticoagulation during cardiopulmonary bypass by aprotinin.
    de Smet AA; Joen MC; van Oeveren W; Roozendaal KJ; Harder MP; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 Oct; 100(4):520-7. PubMed ID: 1699088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation policy during use of aprotinin in cardiopulmonary bypass.
    van Oeveren W; van Oeveren B; Wildevuur CR
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):210-1. PubMed ID: 1377314
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass.
    Hunt BJ; Segal HC; Yacoub M
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):211-2. PubMed ID: 1377315
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternative perioperative anticoagulation monitoring during cardiopulmonary bypass in aprotinin-treated patients.
    Huyzen RJ; Harder MP; Huet RC; Boonstra PW; Brenken U; van Oeveren W
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):153-6. PubMed ID: 7515704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement.
    Wendel HP; Heller W; Gallimore MJ; Bantel H; Müller-Beissenhirtz H; Hoffmeister HE
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):41-5. PubMed ID: 7681331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
    Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrinsic pathway--associated activated clotting time for anticoagulation monitoring during cardiopulmonary bypass.
    Gu YJ; Huyzen RJ; van Oeveren W
    Anesth Analg; 1996 Aug; 83(2):433. PubMed ID: 8694335
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass.
    Veres G; Radovits T; Schultz H; Lin LN; Hütter J; Weigang E; Szabolcs Z; Szabó G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):340-5. PubMed ID: 17500000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of different forms of aprotinin during cardiopulmonary bypass.
    De Bakker A; De Hert S; Vlaeminck R; Delrue G; Govaerts E; Vermeyen K
    Acta Anaesthesiol Belg; 1993; 44(2):45-51. PubMed ID: 7694437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass.
    Dietrich W; Spannagl M; Schramm W; Vogt W; Barankay A; Richter JA
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):505-14. PubMed ID: 1833592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood hibernation: a novel strategy to inhibit systemic inflammation and coagulation induced by cardiopulmonary bypass.
    Zhou J; Wu XD; Lin K; Lui RC; An Q; Tao KY; Du L; Liu J
    Chin Med J (Engl); 2010 Jul; 123(13):1741-7. PubMed ID: 20819640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aprotinin and monitoring of heparin level during cardiopulmonary bypass: preliminary report].
    Tabuchi N; van Oeveren W
    Nihon Geka Gakkai Zasshi; 1994 Jul; 95(7):479. PubMed ID: 7520970
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
    Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
    Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to invited letter concerning: Aprotinin (J Thorac Cardiovasc Surg 1991; 101:1103-4).
    Blauhut B; Lundsgaard-Hansen P
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):386-7. PubMed ID: 1370972
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin resistance during cardiopulmonary bypass. The role of heparin pretreatment.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Mar; 85(3):346-53. PubMed ID: 6827843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.